Dr. McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency, he undertook graduate studies in Dr. Ori Rotstein’s laboratory and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at the Toronto General Hospital, he began his appointment at the University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto.
- Diseases of the liver, particularly viral hepatitis
- Transplant immunology
- Hepatic ischemia/reperfusion injury
- Vascular reconstructive techniques for locally advanced liver and pancreas cancer
- Applicability of transplantation to oncology diagnoses
Live Donor Liver Transplantation With Older (≥50 Years) Versus Younger (<50 Years) Donors: Does Age Matter?
Ann Surg. 2015 Jun 23;
IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research.
Gastroenterol Res Pract. 2015;2015:796461
Clin Transplant. 2015 May 26;
Liver Transpl. 2015 Apr 17;
Liver transplantation in patients with end-stage liver disease requiring intensive care unit admission and intubation.
Liver Transpl. 2015 Apr 10;
Live Donor Liver Transplantation: A Valid Alternative for Critically Ill Patients Suffering From Acute Liver Failure.
Am J Transplant. 2015 Mar 19;
Long-term follow-up of biliary complications after adult right-lobe living donor liver transplantation.
Clin Transplant. 2015 Mar 4;
Vasa. 2015 Mar;44(2):151-5
Transplantation. 2015 Feb;99(2):e13-4
Scientist, Toronto General Hospital Research Institute (TGHRI)
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Associate Professor, Department of Surgery, Faculty of Medicine, University of Toronto